Product
Bromocriptine
5 clinical trials
10 indications
Indication
Peripartum CardiomyopathyIndication
PostpartumIndication
ObesityIndication
SchizophreniaIndication
Pre-DiabetesIndication
FibromyalgiaIndication
PainIndication
ChronicIndication
Chronic PainIndication
WidespreadClinical trial
Randomized Evaluation of Bromocriptine In Myocardial Recovery THerapy for Peripartum Cardiomyopathy (REBIRTH)Status: Recruiting, Estimated PCD: 2026-06-30
Clinical trial
Dopamine Action on Metabolism Depending on Genetic Heterogeneity - a Randomized, Placebo-controlled Double Blind StudyStatus: Recruiting, Estimated PCD: 2024-12-01
Clinical trial
Open-label, Flexible-dose Adjunctive Bromocriptine for Patients With Schizophrenia and PrediabetesStatus: Not yet recruiting, Estimated PCD: 2025-07-31
Clinical trial
The Role of Dopamine in Fronto-striatal Activation in Emotional-motivational Pain Processing in Patients With Chronic PainStatus: Completed, Estimated PCD: 2023-07-31
Clinical trial
Bromocriptine in the Treatment of Peripartum Cardiomyopathy, A Bayesian Randomized Registry TrialStatus: Withdrawn, Estimated PCD: 2023-01-01